These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1782327

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis.
    Cardona A, Garchon HJ, Vernet-der-Garabedian B, Morel E, Gajdos P, Bach JF.
    J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300
    [Abstract] [Full Text] [Related]

  • 23. Lack of inter-animal cross-reaction of anti-acetylcholine receptor antibodies at the receptor-binding site as demonstrated by heterologous anti-idiotype antisera: implications for immunotherapy of myasthenia gravis.
    Barkas T, Simpson JA.
    Clin Exp Immunol; 1982 Jan; 47(1):119-26. PubMed ID: 7094417
    [Abstract] [Full Text] [Related]

  • 24. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity.
    Lennon VA, Lambert EH.
    Ann N Y Acad Sci; 1981 Jan; 377():77-96. PubMed ID: 6176167
    [Abstract] [Full Text] [Related]

  • 25. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B, Morel E, Bach JF.
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [Abstract] [Full Text] [Related]

  • 26. Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: species, subunit and region specificity.
    Tzartos S, Langeberg L, Hochschwender S, Swanson LW, Lindstrom J.
    J Neuroimmunol; 1986 Jan; 10(3):235-53. PubMed ID: 3484485
    [Abstract] [Full Text] [Related]

  • 27. Alteration of the humoral immune response against muscle acetylcholine receptor by timed administration of alpha(1----3)dextran.
    Tong Z, Dwyer DS.
    Eur J Immunol; 1990 Aug; 20(8):1627-34. PubMed ID: 1698629
    [Abstract] [Full Text] [Related]

  • 28. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S, LeBoeuf RD, Blalock JE.
    Proc Natl Acad Sci U S A; 1993 Sep 15; 90(18):8747-51. PubMed ID: 8378359
    [Abstract] [Full Text] [Related]

  • 29. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
    Dwyer DS, Bradley RJ, Urquhart CK, Kearney JF.
    Nature; 1993 Sep 15; 301(5901):611-4. PubMed ID: 6402708
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T, Massa T, Kornfeld P, Papatestas A, Bender A, Genkins G.
    Muscle Nerve; 1981 Sep 15; 4(1):16-25. PubMed ID: 6164920
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evidence against acetylcholine receptor having a main immunogenic region as target for autoantibodies in myasthenia gravis.
    Lennon VA, Griesmann GE.
    Neurology; 1989 Aug 15; 39(8):1069-76. PubMed ID: 2474772
    [Abstract] [Full Text] [Related]

  • 34. Anti-acetylcholine receptor antibody related idiotypes in myasthenia gravis.
    Lefvert AK.
    J Autoimmun; 1988 Feb 15; 1(1):63-72. PubMed ID: 3267109
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M, Donnelly-Roberts D, Richman DP, Martinez-Carrion M.
    J Immunol; 1994 Jun 15; 152(12):5997-6002. PubMed ID: 8207224
    [Abstract] [Full Text] [Related]

  • 37. Acetylcholine receptor antibodies and anti-idiotypic antibodies produced in blood lymphocyte cultures from patients with myasthenia gravis.
    Lefvert AK, Sundén H, Holm G.
    Scand J Immunol; 1986 Jun 15; 23(6):655-62. PubMed ID: 3715409
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ, Cung MT, Demange P, Loutrari H, Mamalaki A, Marraud M, Papadouli I, Sakarellos C, Tsikaris V.
    Mol Neurobiol; 1991 Jun 15; 5(1):1-29. PubMed ID: 1725702
    [Abstract] [Full Text] [Related]

  • 40. Anti-presynaptic membrane receptor antibodies in myasthenia gravis.
    Lu CZ, Link H, Mo XA, Xiao BG, Zhang YL, Qin Z.
    J Neurol Sci; 1991 Mar 15; 102(1):39-45. PubMed ID: 1856731
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.